41.37000 EUR
1.505
3.51%
Last update Dec 16, 8:57 PM CET
Main market
Day range
41.26500
42.55000
Previous close
42.875
Open
42.55000
Access this stock data via API
Subscribe
Novo Nordisk A/S
41.37
1.51
3.51%

Financials

Income statement

Fundamentals currency is DKK
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 10.0B 10.3B 10.5B 11.5B
Cost of revenue 2.4B 1.7B 1.7B 1.7B
Gross profit 7.6B 8.6B 8.7B 9.7B
Operating expense
Research & development 2.1B 1.6B 1.4B 1.8B
Selling general and admin 2.4B 2.5B 2.2B 2.7B
Other operating expenses 15.7M 3.1M -1.9M 246.2M
Operating income 3.2B 4.5B 5.2B 4.9B
Non operating interest income
Income 245.7M 711.4M 458.5M -59.8M
Expense 663.8M 693.9M -82.1M
Other income expense
Pretax income 3.4B 4.5B 5.0B 4.8B
Tax provision 737.8M 977.6M 1.1B 980.9M
Net income 2.7B 3.5B 3.9B 3.8B
Basic EPS 6.0 6.5
Diluted EPS 6.0 6.5
Basic average shares 595.3M 594.4M
Diluted average shares 595.3M 595.3M
EBITDA 4.2B 5.8B 6.2B 4.7B
Net income from continuing op. 2.7B 3.5B 3.9B 3.8B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 55 minutes

12:04
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).